- Release Date: 15/02/23 08:10
- Summary: Mayne Pharma to restate US dermatology net revenue for FY22
- Price Sensitive: Yes
- Download Document 126.64KB
Ann: Mayne Pharma to restate US dermatology net revenue for FY22
Add to My Watchlist
What is My Watchlist?